Delivery Order SPE2DE21D7010-SPE2D625F4NJ8
- Not listed
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
- This federal contract award is for $40,819.90 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of June 30, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is not associated...
- This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
- This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
- This federal contract award is a delivery order (SPE2DE21D7010|SPE2D625F0N6K) valued at $31,469.80 issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract provides a range of spinal medical devices and surgical instruments to support orthopedic, neurological, and reconstructive surgeries at...
- This federal contract award, valued at $17,360.46, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of February 21, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and operates as a for-profit...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and the ultimate completion date is April 18, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract does not have a...
- This federal contract award, valued at $46,038.63, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, with a period of performance ending on March 17, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is part of a larger $8 million Blanket...
- This federal contract award is a delivery order valued at $12,969.84 to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is funded by the Defense Logistics Agency (DLA) Medical Supply Chain and does not have a set-aside designation, indicating Nuvasive competes in open market procurements. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, provides a range of specialized spinal medical technologies,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F4NJ8Delivery Order
This federal contract award is a delivery order worth $23,660.61 issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of July 21, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical technologies, implants, instruments, biologics, and related surgical equipment to federal healthcare agencies, primarily the Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA). The contract is not associated with any set-aside designation, indicating Nuvasive competes successfully in open market procurements. Nuvasive also holds significant Indefinite Delivery Vehicle (IDV) contracts, including an $8 million Blanket Purchase Agreement (BPA) with the DHA, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle through March 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 6/30/25 |